Also found in: Medical.
Related to antiplatelet: antiplatelet antibody


 (ăn′tē-plāt′lĭt, ăn′tī-)
Acting against or destroying blood platelets.
Mentioned in ?
References in periodicals archive ?
The poor performance of this dual antiplatelet combination in this large study, called the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, leaves the secondary stroke prevention guideline published last year by the American Heart Association and American Stroke Association unchanged in its recommendation of three antiplatelet drug options for patients with a history of stroke or transient ischemic attack: aspirin, aspirin plus dipyridamole, or clopidogrel (Stroke 2011;42:227-76), Dr.
For patients who must take clopidogrel for atherosclerosis but have a history of peptic ulcer, the addition of esomeprazole to the antiplatelet therapy can prevent recurrent peptic ulcer, Dr.
Therefore, patients on either antiplatelet agents or full anticoagulation therapy with warfarin are usually managed with other modes of therapy or their anticoagulation agents are held perioperatively.
Antiplatelet therapy is the current criterion standard for the treatment of patients undergoing percutaneous coronary intervention and patients who have acute coronary syndromes.
Concomitant use of low-dose aspirin and ibuprofen may interfere with aspirin's antiplatelet effects, possibly attenuating its cardioprotective benefits, according to the Food and Drug Administration.
This approach to dealing with patients on long-term treatment with the antiplatelet drug clopidogrel (Plavix) was endorsed also by Ron Waksman, M.
These include lipid-lowering drugs and antiplatelet agents, such as aspirin, he says.
The studies on whether dialysis reduces the efficacy of dual antiplatelet drugs are limited.
We present a case of gastrointestinal bleeding due to antiplatelet therapy after percutaneous coronary intervention (PCI) and secondary in-stent thrombosis due to discontinuation of antiplatelet drugs.
Concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, and other antiplatelet agents further increases the risk of the latter.
In contrast to European and American guidelines that recommend pre-hospital antiplatelet therapy for heart attack patients suffering from ST-elevation myocardial infarction (STEMI), a new study presented at ESC Congress (1) suggests this practice has no advantage over waiting for in-hospital treatment.